Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02152215 · ClinicalTrials.gov registry record · Phase 4
Ridge Preservation Comparing a Polylactic Acid Membrane vs. an Acellular Dermal Matrix Membrane
A Phase 4 study, sponsored by University of Louisville.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT02152215 is a Phase 4 study that has completed, run by University of Louisville. The registered enrollment target is 22 participants.
The verdict
NCT02152215, a Phase 4 study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the clinical and histologic outcomes for acellular dermal matrix and resorbable membranes to determine if either provides a significant therapeutic advantage.
Interventions
- PROCEDURE Acellular dermal matrix membrane
- PROCEDURE Polylactic acid membrane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02152215
The ClinicalTrials.gov registry entry for NCT02152215 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acellular dermal matrix membrane is the first listed.
NCT02152215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02152215 about?
NCT02152215 is a clinical study titled "Ridge Preservation Comparing a Polylactic Acid Membrane vs. an Acellular Dermal Matrix Membrane". The purpose of this study is to compare the clinical and histologic outcomes for acellular dermal matrix and resorbable membranes to determine if either provides a significant therapeutic advantage.
What is the current status of trial NCT02152215?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2014-07. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02152215?
The interventions under investigation include: Acellular dermal matrix membrane (PROCEDURE), Polylactic acid membrane (PROCEDURE).
Who is sponsoring clinical trial NCT02152215?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.